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Edited by Robert B. RussellAbstract The second messenger cyclic Adenosine MonoPos-
phate (cAMP) mediates many biological process by interacting
with structurally conserved nucleotide binding domains
(cNBDs). Here, we use molecular dynamics simulations on
RIIb-PKA, one of the best characterized members of the cNBD
family, in presence and absence of cAMP. The results of our cal-
culations are fully consistent with the available experimental
data and suggest that the key factor of the cAMP allosteric
mechanism in cNBDSs is the increased ﬂexibility of the protein
upon ligand release along with a mechanical coupling between
helical segments. In addition, our calculations provide a rationale
for the experimentally observed cAMP selective binding to PKA.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The ubiquitous second messenger cyclic Adenosine Mono-
Posphate (cAMP) [1,2] mediates a large variety of cellular pro-
cesses by interacting with highly specialized protein modules
called cyclic nucleotide binding domains (cNBDs) [3–7]. These
protein modules feature a conserved a/b architecture (Fig.
1(a)) [8–15].
One of the most characterized cNBDs is found in the mul-
tisubunit protein kinase A (PKA) [16]. PKA is a tetramer con-
sisting of a dimer of the so-called regulatory subunits (R-PKA,
which exist in four homologous isoforms RIa, RIIa, RIb and
RIIb [17,18]) and two separated catalytic subunits (C-PKA).
Two tandem cAMP binding domains are located at the C-ter-
mini of R-PKA. In the inactive form, a N-terminal pseudosub-
strate peptide of R-PKA binds into the active site of C-PKA
inhibiting its catalytic activity. Binding of cAMP to R-PKA
causes its dissociation from C-PKA and consequent activation
of the two C-PKA subunits.
The two cNBDs of R-PKA (A and B, Fig. 1(a)) are posi-
tioned one after the other with the C helix of domain A (CA)
linking to the A helix of domain B (AB). X-ray studies on*Corresponding author. Fax: +39 049 7923250.
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doi:10.1016/j.febslet.2005.02.084the R-PKA Æ 2cAMP complexes [9,13] have revealed that in
both binding sites, cAMP phosphate moiety forms a salt
bridge with a fully conserved Arg residue in the so-called
phosphate binding cassette (PBC), while the nucleobase forms
extensive contacts with residues from the CB helix. Site A,
which does not interact with helix CA, is more accessible to
cAMP than site B, which is instead occluded by helix CB
(Fig. 1). Consistently, site A displays a higher ligand oﬀ-rate
[19] (s1/2 = 1 min, against s1/2 = 30 min for site B) in R-PKA
not complexed with C-PKA while it has smaller aﬃnity for
cAMP than site B in the entire PKA holoenzyme not bound
to any ligand [20,21].
The molecular details of the cAMP allosteric mechanism are
not yet known. Deuterium exchange and mutational studies
have established that in the holoenzyme tetramer C-PKA con-
tacts R-PKA only at the ﬁrst binding domain [22] and that the
exposition of the binding sites increases upon ligand release.
Circular dichroism (CD) experiments point to a decrease of
helical content upon ligand release [23]. Accordingly, in the
X-ray structure of EPAC2 [11], a related cNBD protein crys-
tallized in absence of cAMP, the electron density of the C helix
could not be detected probably because of the high mobility of
this segment. Similarly, in the recently reported structures of
cNBD of the Mesorhizobium loti K+ channel [24] in absence
of cAMP and of RIa-PKA with only site A occupied by a
cGMP molecule 1 [14] both C helices showed high B-factor
values and the last residues were not detected.
Understanding the molecular mechanism triggered by
cAMP is central to describe PKA biological function. In addi-
tion, it may help understand the regulation on cardiac and
neuronal activities trough cyclic nucleotides modulated chan-
nels [12] and may also allow for the design of new and opti-
mized in vivo cAMP molecular sensors [25,26].
Here, we use molecular dynamics (MD) simulations to ad-
dress fundamental issues about this mechanism: (i) Which
are the conformational changes associated to ligand release
and uptake? (ii) Which is the mechanism through cAMP binds
or leaves selectively from site A in the uncomplexed R-PKA
and bind site B in the PKA holoenzyme?
We focus on RIIb-PKA isoform, as its cAMP bound struc-
ture is known [13,27] and it has been successfully used in sev-
eral ﬂuorescent cAMP proves that exploit the conformational
changes generated by cAMP [26,28]. Nevertheless, we may1 The cloud of electronic density observed in site B was ascribed to a
glycerol molecule.
blished by Elsevier B.V. All rights reserved.
Fig. 1. (a) Cartoon representing the two tandem cyclic nucleotide
binding domains (cNBDs), as found in R-PKA subunit. Each domain
features a short helical segment (A), a second a-helix (B), a b-roll made
of 8 b-strands arranged in a jelly roll like topology with one short
internal a-helix (P) and a kinked C terminal a-helix (C). Secondary
structure elements of the ﬁrst and second binding domains have
subscripts A and B, respectively. The two cAMP binding sites are
indicated. Notice that helix CA constitutes the only covalently bound
connection between the two cNBDs. (b, c) View of the 3D structure of
RIIb-PKA (PDB code: 1CX4) (b) in complex with cAMP (represented
as van der Waals spheres) in both binding sites, as obtained by X-ray
crystallography [13] and (c) and in the free state, as obtained after
27 ns of MD performed in this work. Labeling as in (a). Coloring
scheme: for a helices, pink (light pink for the residues slightly deviating
from helical conformation); for b strand, yellow; for coil: white; for
turn, cyan. cAMPs are colored by atom type.
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ally transferable to other R-PKA isoforms.
Based on MD simulations in the presence and in the absence
of ligands, we suggest that the lack of ligands drives the struc-
ture towards a less ordered state in which some helical ele-
ments are disordered (Fig. 1(c)) and both binding domains
oscillate one respect to the other. This conformational state
is consistent with experimental data of other cNBDs, includ-
ing X-ray crystallography [11,14,24] deuterium exchange
[22,29–31], Trp ﬂuorescence [32] and CD data [23]. In addition,
we identify a mechanical coupling between the two binding do-
mains which is an important factor for the aﬃnities of the two
binding sites. Finally, although calculations on the PKA holo-
enzyme are unfeasible due to the lack detailed structural infor-
mation, we provide a hypothetic reason for the higher aﬃnity
of site B relative to A in the PKA holoenzyme. Given the high
structural conservation of cNBD motifs from bacterial toeukariotic cells, it can be expected that they all share a similar
allosteric mechanism.2. Methods
Structural model. We focus on the 111 residues N-terminal deletion
mutant (D1-111) structure of the RIIb isoform PKA with two bound
cAMP molecules (RIIb-PKA Æ 2cAMP, PDB code: 1CX4), determined
by X-ray diﬀraction at 2.45 A˚ resolution (Fig. 1(b)) [13,27]. The poly-
peptide chain determined by X-ray crystallography comprises aa from
130 to 413, spanning both cAMP binding sites. Residues 326–333 cor-
responding to loop 4 in the second binding domain were not detected
in the X-ray electron density map. Here, they are generated using the
loop reﬁnement option of Modeller v6.2 [33,34]. As expected, this loop
features a large ﬂexibility during MD simulations and no intramolec-
ular interactions with the rest of the protein scaﬀold.
We focus on: (i) The free form of RIIb-PKA from which both cAMP
molecules are removed. (ii) RIIb-PKA with one cAMP bound on site
A. (iii) RIIb-PKA with two cAMP molecules bound. Those three sys-
tems are simulated for 27, 6 and 3 ns, respectively. The simulation
times for the diﬀerent systems are set according to the dynamical
behavior and stabilization of each system. A linear ﬁt over the RMSD
from the initial structure calculated over the CA atoms during the last
ns of simulation on systems ii and iii yield a nearly horizontal line with
slopes 0.005 and 0.001, respectively, suggesting that they reach a stable
state.
The three systems are immersed in a simulation box containing
15 300 water molecules and neutralizing Na+ counterions (4, 3
and 2 for systems i, ii and iii, respectively). MD calculations are car-
ried out with the MDRUN module of Gromacs 3.1 suite of programs
[35]. Periodic rectangular boundary conditions are used with Particle
mesh Ewald summation method [36] for long-range electrostatic
interactions. A 10 A˚ cutoﬀ is adopted for short-range non-bonded
interactions with a dielectric constant of 1. All chemical bonds
involving hydrogen atoms are constrained using the LINCS algo-
rithm [37]. A time step of 1.5 fs is used. Temperature and pressure
are keep constant at 300 K and 1 atm, respectively, by coupling the
system to external baths [38–40]. For the protein, counterions and
water, the AMBER94 [41] force ﬁeld and TIP3P model [42] are used.
The parametrization of cAMP is that developed by us in an MD
study of another cNBD [43]. The systems undergo: (i) energy minimi-
zation, (ii) 0.03 ns MD of the solvent and counterions, (iii) six MD
simulation steps each lasting 0.2 ns raising the temperature by 50 K
each, (iv) MD simulations at room conditions of 27, 6 and 3 ns for
systems i, ii and iii, respectively.
Calculated properties. Hydrogen bonds between a donor (X–H) and
an acceptor (Y) are assumed to exist if: (i) d(X–Y) < 3.5 A˚; (ii) \(X–H–
Y) > 120. Ellipticity at 222 nm was calculated according to the Hirst
and Brooks [44] method. The solvent accessible surfaces on the binding
sites are calculated using a prove radius of 1.4 A˚ [45]. The binding sites
are deﬁned as all the residues within 5 A˚ of any cAMP atom measured
in the X-ray structure for both of the binding sites. These comprise
Ile180, Ile199-Val201, Val210, Tyr213, Ser218-Gly220, Pro229-Ile334,
Gln377 and Arg381 for site A and Ile302, Ile321, Met323, Ile339,
Ala340, Tyr347-Ala352, Tyr397, Gln400, Leu401 and Ile411 for site B.
Molecular graphics and calculation of secondary structure elements
against simulated time are performed with VMD (http://www.ks.
uiuc.edu/Research/vmd/).3. Results and discussion
Aimed to describe the dynamical properties of RIIb-PKA in
their bound and free state we perform here MD simulations of
RIIb-PKA in complex with two cAMP molecules and in the
free state. Moreover, to gain insights on the dynamic features
of the allosteric mechanism of PKA triggered by cAMP we
undertake the simulation of RIIb-PKA in complex with one
cAMP bound to site A since this site is the ﬁrst to be occupied
[46]. Furthermore, the availability of a crystallographic
S. Pantano et al. / FEBS Letters 579 (2005) 2679–2685 2681structure of RIa-PKA bound to cGMP at site A [14] allows a
qualitative comparison with our results.
The ﬁndings obtained from the three systems simulated here
are then extended to other cNBDs and used to propose a
mechanism for the cAMP allosteric reaction.
We notice that although a simulation of R-PKA bound to
site B could deepen our understanding on the communication
mechanism between both binding sites and, eventually, on the
communication between R and C-PKA, a structure of the R–C
holoenzyme where cAMP binds ﬁrst to site B is presently not
available and therefore it is possible neither to reliably predict
the conformational changes produced on R-PKA upon the
protein–protein interaction with C-PKA, nor to diﬀerentiate
them from those deriving of the occupation of the binding
sites.
RIIb-PKA Æ 2cAMP. The structure, built from the X-ray
structure of the protein of (D1-111) RIIb-PKA (PDB code:
1CX4), rapidly equilibrates with an RMSD oscillating aroundFig. 2. Structural properties from the MD simulations of RIIb-PKA. (a–c) R
RIIb-PKA Æ 2cAMP (a), RIIb-PKA Æ cAMP (bound to site A, b) and in the fr
and of cAMP (sites A and B) are colored in black, red, green, light blue, dark
for the three systems with the same time scale. RMSD of the free simulation (
and double bound cAMP, respectively). (d–f) Properties of the free protein. (
(gray, lower) and B (black, upper). (e) Ramanchandran plot of the CA (circle
conformers. Most favored regions are indicated with dashed lines. (f) Lef
simulation time. Coloring scheme as Fig. 1(b) and (c). Right: B factors report
were structurally aligned to their corresponding domains on the initial MD2 A˚ (Fig. 2(a)). The resulting structure after MD simulation is
very similar to the X-ray structure (Fig. 2(a)). Both CA and CB
helices of sites A and B conserve a stable helical conformation
although they show a higher mobility than the whole protein.
As in all the structures of R-PKA [9,13,14,47], the helical mo-
tifs AB and BB lie between and mediate the contacts among
helices CA and CB. Both cAMP molecules remain well within
their binding sites displaying a similar mobility with an average
RMSD of 1.2 A˚.
RIIb-PKA Æ cAMP. Since cAMP binds preferentially to site
A [19] the initial structural model was obtained by removing
cAMP in site B from the X-ray structure.
During the dynamics the secondary structure elements of do-
main A retained their global integrity similarly to the initial
structural model, in particular that of the helix CA as shown
by its RMSD behavior (Fig. 2(b)) and by a comparison with
the X-ray structure (Fig. 3(a)). Instead, domain B displays a
higher mobility as seen from the calculated B-factors alongMSD from the initial conformer vs. time calculated over Ca atoms for
ee state (c). The RMSDs of the whole protein, of the CA and CB helix
blue, respectively. The inset in (c) presents a comparison of the RMSD
gray) is higher than the other two cases (light gray and black for simple
d) Solvent accessible surface vs. simulated time for the binding sites A
s) and CB motifs (triangles) in the initial (ﬁll blue) and ﬁnal (open red)
t: Presence of secondary structure elements plotted as a function of
ed for the X-ray structure of the free protein EPAC2 [11]. Both cNBD
conformer of the RIIb-PKA structure [13].
Fig. 3. MD structure of RIIb-PKA with cAMP bound at site A. (a)
Superposition of the initial (X-ray structure, PDB code 1CX4) and
ﬁnal (after 6 ns) MD conformers colored in gray and by structure,
respectively, as in Fig. 1(b) and (c). cAMPs at site A are white and
green for initial and ﬁnal, respectively. Gln377 and Arg381 whose side
chains contact cAMP are presented in balls and stick. (b) Cartoon
representation of RIa-PKA with cGMP bound at site A (PDB code:
1RL3) [14]. (c) Temperature factors from RIIb-PKA with cAMP
bound to site A from MD simulation (black line) and from the crystal
structure of RI-PKA with cGMP bound at site A. This crystal
structure contained two proteins in the unitary cell (named A and B in
the PDB ﬁle), thermal factors for molecules A and B are light and dark
gray, respectively. Comparison of the MD derived B factors shows
higher values in the second half domains of the protein in qualitative
agreement with RIa-PKA Æ cGMP. Since sequence number diﬀer for
both isoforms, residues are renumbered, residue 1 correspond to 109 in
RIa and to 130 in RIIb. The vertical dashed line indicates the border
point between both domains.
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with those derived by X-ray data on RIa PKA Æ cGMP
(PDB code 1RL3) [14] (Fig. 3(b) and (c)).
The most movable region of domain B is helix CB whose
RMSD is 1 A˚ larger than the global RMSD (Fig. 2(b)),
adopting a more markedly kinked conformation (Fig. 3(a)).
Of particular note is the RMSD behavior of the cAMP bound
at site A. Comparison with the analogous molecule of the
RIIb-PKA Æ 2cAMP simulation indicates a much higher
mobility in the single bound case. This behavior may be ex-
plained due to the direct contacts established between the
nucleobase moiety and the side chains of Gln377 and
Arg381, at the beginning of the CB helix (Fig. 3(a)). This estab-
lish a communication mechanism that may be consistent with
the fact that binding of cAMP to site A retards the release of
cAMP from site B [21] and with ﬂuorescence experiments on
Trp243 showing that domain A senses the occupation state
of site B [30], since the presence of a cAMP molecule at siteTable 1
Inter domain H-bond interactions in the MD simulation of free RIIb-PKA
Donor Arg262(Ng) Gln377(Ne2) T
Acceptor (1CX4 [27]) Asp288(Od) Asn212(O) A
Donor Arg262(Ne) Lys293(Nf) L
Acceptor (MD 17 to 27 ns) Asp288(Od) Asp149(Od) T
Only the H-bond interactions in the ﬁrst column are conserved.A could help to stabilize the site B by limiting CB helix
ﬂuctuations.
Free RIIb-PKA. This system has the same starting conﬁgu-
ration of the previous for the protein but both cAMP mole-
cules are removed. Because of the lack of both ligands, a
longer time scale is required in this case to equilibrate the sys-
tem. In fact, the RMSD increases signiﬁcantly during as many
as 17 ns, reaching only after this time a stationary state char-
acterized by very large oscillations (Fig. 2(c)).
The calculated solvent accessible surface areas of the whole
protein experiences an increase of 5% passing from 967 to
1010 A˚2 in the ﬁnal state. The same quantity calculated for
the cAMP binding sites A and B increase by 5% and 3% re-
spect to the initial conformer, respectively (Fig. 2(d)), pointing
to a more open conformation of the binding sites in absence of
the ligands. This is consistent with the higher exposition ob-
served in deuteration experiments on amide groups of free
RIa and RIIb-PKA in the cAMP free form [29,31,48].
The CB helix, that in the double bound case forms extensive
interactions with the nucleobase moiety of cAMP (in particu-
lar Tyr397) shows a high mobility already in the ﬁrst part of
the simulation: the RMSD reach 3.5 A˚ at 2.2 ns and oscillates
around 4 A˚ from 5 to 10 ns. These large values are associated
to a rearrangement in which the ordered helical conformation
present in the ligand-bound structure evolves to a more disor-
dered and dynamical conformation that, however, retain some
helical character (Fig. 2(e)). Also the CA helix, at the end of the
ﬁrst binding domain, evolve also towards a disordered, nearly
helical state (Fig. 2(e)). After 17 ns, the increased mobility of
CA helix determines a separation of the two cNBDs (Fig.
1(c)), as helix CA is the only link between the two domains
(Fig. 1(a)). This implies a reduction of the interdomain inter-
face area and the loss of several H-bond interactions (Table
1). The only maintained interaction involves Arg262 and
Asp288, while two new H-bonds (Lys154-Thr292 and
Lys293-Asp149) form and break during the last 10 ns. The
ﬂuctuating character of these interactions may prevent the
complete detachment of the two domains [18]. Also the short
AA and AB helices evolve towards a more disordered state sim-
ilarly to helices CA and CB (Fig. 2(f)). Instead, helices BA and
BB are maintained (Fig. 2(f)). As a result, the calculated helical
content [44] decreases by 10% relative to the RIIb-PKA Æ
2cAMP simulation, consistent with the decreased degree of
helical content of the free form of RIIb and RIa PKA obtained
from CD data [23,49].
The average maximum linear dimension of the protein in-
creases from 60 A˚ (in the initial model) to 70 A˚. Thus, this
simulation suggest that in absence of cAMP R-PKA adopt a
more ﬂexible structure that with some lost of helical content
without undergoing dramatic conformational transitions nor
unfolding [19,46,48,50,51].
In spite of the decrease of the overall helical content, motifs
AB and BB mediate the contacts among helices CA and CB as inyr226(Oc) Lys261(Nf) Arg262(Ng) Lys276(Nf)
sp288(Od) Asp288(O) Leu284(O) Glu270(O)
ys154(Nf)
hr292(O)
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tween both binding domains. This coupling may be also con-
sistent with experimental data of cNBDs homologous
proteins, namely: (i) mutations at the beginning (so called
hinge) of C helix in the EPAC1 protein, alter the conforma-
tional changes triggered by cAMP [11]; (ii) the deletion of C
helix in the cNBD of the HCN2 channel abolish cAMP mod-
ulation [52]; (iii) comparison between the free and cAMP
bound conformations of the Mesorhizobium loti K+ channel
[24] clearly shows a concerted motion of the motifs named
aC, aA 0 aA and the nearly helical segment between aA 0 and
aA (corresponding to ours CB, CA, BB and AB) [24].
The structurally most conserved regions of the protein are
the two b-roll motifs, which oscillate as rather rigid bodies dur-
ing the dynamics (Fig. 2(f)). This is consistent with the rela-
tively low temperature factors obtained for the homologous
motifs in the EPAC2 X-ray structure [11] (Fig. 2(f)).
In the ﬁnal loose conformation we observed, as found for
EPAC2 [11] and Mesorhizobium loti [24] cNBDs, a concerted
movement between Leu224 (within the PBC of site A) and
Phe250 (within helix CA). This feature however was not found
in the corresponding residues of domain B, probably due to
the presence of Pro385 on the opposite side of helix CB (this
proline is present uniquely in sites B of R-PKA).
3.1. A rationale for cAMP selective binding in R-PKA
We provide here a qualitative explanation of the mechanism
of R-PKA for selective cAMP binding to the free form, release
from the RIIb-PKA Æ 2cAMP complex and binding to the com-
plexed form with C-PKA.
Free R-PKA. In the free state cAMP binds preferentially to
site A [20,21]. Comparison between both binding sites from the
crystal structure of RIIb-PKA Æ 2cAMP indicate that the CB
helix is a fundamental ingredient of the binding site B – it
forms extensive interactions with the nucleobase moiety ofFig. 4. Proposed molecular mechanism of allosteric reaction in PKA: cAM
dissociation (bottom). Curved arrows indicate stabilizing interactions betweecAMP, in particular Tyr397. In contrast, in site A, cAMP
interacts mainly with residues within the rigid b-rolls (contact-
ing Ile199, Val201, Tyr213, Phe219, Leu222, Ala231, Ala232,
Ile234) and, to a lesser extent, the beginning of CB helix (side
chains of Gln377 and Arg381). No contacts are formed with
the CA helix. Therefore in the loose and more extended confor-
mation found in our simulation, site A is less distorted and
can accommodate the substrate much better than site B [53]
(Fig. 4(a1)). Once one molecule of cAMP binds to site A,
the contacts between the adenine moiety of cAMP and
Gln377/Arg381 limit the mobility of helix CB (Fig. 4(a2)), as
observed in our simulation with one cAMP bound at site A.
These contacts may recompose the geometry of site B increas-
ing its aﬃnity for cAMP [51]. After cAMP binding to site B the
rigidity of helix CB ﬁxes helices AB and BB that, at their time,
stabilize helix CA (Fig. 4(a3)), driving the protein to a the rigid
double bound structure (Fig. 4(a4)).
RIIb-PKA Æ 2cAMP. In the doubly bonded state [13]
(Fig. 1(b)), cAMP at site B is occluded by CB helix (Fig.
4(b1)), so that it can not be released unless by a rise in
the ﬂexibility of CB helix. Site A, instead is not occluded
and it allows for ligand release. An unoccupied site A may
facilitate cAMP release from site B since CB helix can gain
ﬂexibility due to the lack of stabilizing contacts with
Gln377/Arg381 owing to the absence of the cAMP in the
ﬁrst binding domain (Fig. 4(b2)). At the same time, a empty
site A may drive helix CA into a disordered state. The move-
ments in helix CA may be transmitted to CB trough direct
contacts with AB and BB. This double destabilization mech-
anism implies (Fig. 4(b2) and (b3)) a cooperative release of
both ligands so that R-PKA gets ready (Fig. 4(b4)) to inhibit
the catalytic subunit once the local concentration of cAMP
decreases.
R-PKA/C-PKA complex. Here we attempt to draw conclu-
sions on the preferred binding of cAMP to site B when inP binding (top), release (middle) and cAMP mediated holoenzyme
n diﬀerent structural motifs.
2684 S. Pantano et al. / FEBS Letters 579 (2005) 2679–2685complex with C-PKA. Because of the impossibility to simulate
such complex, such conclusions are clearly more speculative
than those in the previous sections.
We reason based in the following facts: (i) in RIIb-PKA, he-
lix CA is very ﬂexible when not complexed with C-PKA, as
shown by this work, (ii) in RIIb and RIa-PKA, only domain
A (Fig. 1) of R-PKA forms contacts with C-PKA [22], (iii)
in RIa/C-PKA complex, C-PKA binding induces large confor-
mational changes on R-PKA [54–56].
Thus, as seen for RIa/C-PKA complex, in absence of cAMP
the ﬂexible helical elements of domain A of R-PKA adopt a
diﬀerent conformation due to induced ﬁt upon binding to C-
PKA [54] changing the orientation of the PBC [56]. As a con-
sequence cAMP binding preference shifts from site A to site B
[47,51] (Fig. 4(c1)). After cAMP binding to site B of the R-
PKA/C-PKA complex, the helical element CB may increase
its helical content, thus reducing its spatial ﬂuctuations (Fig.
4(c2)). This in turn may cause a conformational transition in
helix CA trough direct contacts among CB–AB, BB–CA (Fig.
4(c2)) that modify the position of helices AA and BA and PA,
partially restoring the integrity of site A. This may allow bind-
ing of cAMP to this site. Double cAMP binding may ﬁnally
drive the protein to an ordered conformation similar to that
determined by X-ray crystallography, decreasing the degree
of surface complementarity as suggested by previous rigid
docking calculations [57], thus mediating the dissociation of
the regulatory and catalytic subunits (Fig. 4(c3)) [16,18].4. Conclusions
We provide here a structural model of R-PKA, which is
consistent with all available experimental data on all R-PKA
isoforms and other CNBDs. Based on this model, we conclude
that the large ﬂexibility and the contacts between CA and CB
helices is a salient feature of the cAMP-assisted allosteric
mechanism for this class of proteins and we propose a rationale
for cAMP selective binding in R-PKA (Fig. 4), which involve a
series of coil-to-helix transitions in a sort of domino eﬀect.
Acknowledgements: This work is ﬁnancially supported by the Italian
Istituto Nazionale della Materia (INFM) and Regione Friuli Venezia
Giulia to SP and PC and by Fondazione Cariparo to SP. MZ is sup-
ported by Telethon Italy (TCP00089), the Italian Cystic Fibrosis Re-
search Foundation, the Fondazione Compagnia di San Paolo and
the European Union (QLK3-CT-2002-02149). We also thank Roberto
Battistutta and Alejandro Giorgetti for useful discussions.References
[1] Beavo, J.A. and Brunton, L.L. (2002) Cyclic nucleotide research –
still expanding after half a century. Nat. Rev. Mol. Cell Biol. 3,
710–718.
[2] Kopperud, R., Krakstad, C., Selheim, F. and Doskeland, S.O.
(2003) cAMP eﬀector mechanisms. Novel twists for an old
signaling system. FEBS Lett 546, 121–126.
[3] Ozaki, N., Shibasaki, T., Kashima, Y., Miki, T., Takahashi, K.,
Ueno, H., Sunaga, Y., Yano, H., Matsuura, Y., Iwanaga, T.,
Takai, Y. and Seino, S. (2000) cAMP-GEFII is a direct target
of cAMP in regulated exocytosis. Nat. Cell Biol. 2, 805–
811.
[4] Holz, G.G. (2004) Epac: A new cAMP-binding protein in support
of glucagon-like peptide-1 receptor-mediated signal transduction
in the pancreatic beta-cell. Diabetes 53, 5–13.[5] Torgersen, K.M., Vang, T., Abrahamsen, H., Yaqub, S. and
Tasken, K. (2002) Molecular mechanisms for protein kinase A-
mediated modulation of immune function. Cell Signal 14, 1–9.
[6] Kandel, E.R. (2001) The molecular biology of memory storage: a
dialogue between genes and synapses. Science 294, 1030–1038.
[7] Bos, J.L. (2003) Epac: a new cAMP target and new avenues in
cAMP research. Nat. Rev. Mol. Cell Biol. 4, 733–738.
[8] Weber, I.T. and Steitz, T.A. (1987) Structure of a complex of
catabolite gene activator protein and cyclic AMP reﬁned at 2.5 A˚
resolution. J. Mol. Biol. 198, 311–326.
[9] Su, Y., Dostmann, W.R., Herberg, F.W., Durick, K., Xuong,
N.H., Ten Eyck, L., Taylor, S.S. and Varughese, K.I. (1995)
Regulatory subunit of protein kinase A: structure of deletion
mutant with cAMP binding domains. Science 269, 807–813.
[10] Passner, J.M., Schultz, S.C. and Steitz, T.A. (2000) Modeling
the cAMP-induced allosteric transition using the crystal structure
of CAP-cAMP at 2.1 A˚ resolution. J. Mol. Biol. 304, 847–
859.
[11] Rehmann, H., Prakash, B., Wolf, E., Rueppel, A., de Rooij, J.,
Bos, J.L. and Wittinghofer, A. (2003) Structure and regulation of
the cAMP-binding domains of Epac2. Nat. Struct. Biol. 10, 26–
32.
[12] Zagotta, W.N., Olivier, N.B., Black, K.D., Young, E.C., Olson,
R. and Gouaux, E. (2003) Structural basis for modulation and
agonist speciﬁcity of HCN pacemaker channels. Nature 425, 200–
205.
[13] Diller, T.C., Madhusudan, Xuong, N.H. and Taylor, S.S. (2001)
Molecular basis for regulatory subunit diversity in cAMP-
dependent protein kinase: crystal structure of the type II beta
regulatory subunit. Structure (Camb.) 9, 73–82.
[14] Wu, J., Brown, S., Xuong, N.H. and Taylor, S.S. (2004) RIalpha
subunit of PKA: a cAMP-free structure reveals a hydrophobic
capping mechanism for docking cAMP into site B. Structure
(Camb.) 12, 1057–1065.
[15] Berman, H.M., Ten Eyck, L.F., Goodsell, D.S., Haste, N.M.,
Kornev, A. and Taylor, S.S. (2005) The cAMP binding domain:
an ancient signaling module. Proc. Natl. Acad. Sci. USA 102, 45–
50.
[16] Taylor, S.S., Yang, J., Wu, J., Haste, N.M., Radzio-Andzelm, E.
and Anand, G. (2004) PKA: a portrait of protein kinase
dynamics. Biochim. Biophys. Acta 1697, 259–269.
[17] Canaves, J.M. and Taylor, S.S. (2002) Classiﬁcation and phylo-
genetic analysis of the cAMP-dependent protein kinase regulatory
subunit family. J. Mol. Evol. 54, 17–29.
[18] Vigil, D., Blumenthal, D.K., Heller, W.T., Brown, S., Canaves,
J.M., Taylor, S.S. and Trewhella, J. (2004) Conformational
diﬀerences among solution structures of the type Ialpha, IIalpha
and IIbeta protein kinase A regulatory subunit homodimers: role
of the linker regions. J. Mol. Biol. 337, 1183–1194.
[19] Ogreid, D. and Doskeland, S.O. (1981) The kinetics of association
of cyclic AMP to the two types of binding sites associated with
protein kinase II from bovine myocardium. FEBS Lett. 129, 287–
292.
[20] Doskeland, S.O., Ogreid, D., Ekanger, R., Sturm, P.A., Miller,
J.P. and Suva, R.H. (1983) Mapping of the two intrachain cyclic
nucleotide binding sites of adenosine cyclic 3 0,5 0-phosphate
dependent protein kinase I. Biochemistry 22, 1094–1101.
[21] Doskeland, S.O. and Ogreid, D. (1984) Characterization of the
interchain and intrachain interactions between the binding sites of
the free regulatory moiety of protein kinase I. J. Biol. Chem. 259,
2291–2301.
[22] Anand, G.S., Law, D., Mandell, J.G., Snead, A.N., Tsigelny, I.,
Taylor, S.S., Ten Eyck, L.F. and Komives, E.A. (2003) Identi-
ﬁcation of the protein kinase A regulatory RIalpha-catalytic
subunit interface by amide H/2H exchange and protein docking.
Proc. Natl. Acad. Sci. USA 100, 13264–13269.
[23] Johnson, D.R. and Wong, S.S. (1989) Conformational changes of
type II regulatory subunit of cAMP-dependent protein kinase on
cAMP binding. FEBS Lett. 247, 480–482.
[24] Clayton, G.M., Silverman, W.R., Heginbotham, L. and Morais-
Cabral, J.H. (2004) Structural basis of ligand activation in a cyclic
nucleotide regulated potassium channel. Cell 119, 615–627.
[25] Zaccolo, M. (2004) Use of chimeric ﬂuorescent proteins and
ﬂuorescence resonance energy transfer to monitor cellular
responses. Circ. Res. 94, 866–873.
S. Pantano et al. / FEBS Letters 579 (2005) 2679–2685 2685[26] Nikolaev, V.O., Bunemann, M., Hein, L., Hannawacker, A. and
Lohse, M.J. (2004) Novel single chain cAMP sensors for
receptor-induced signal propagation. J. Biol. Chem. 279, 37215–
37218.
[27] Diller, T.C., Xuong, N.H. and Taylor, S.S. (2000) Type II beta
regulatory subunit of cAMP-dependent protein kinase: puriﬁca-
tion strategies to optimize crystallization. Protein Expr. Purif. 20,
357–364.
[28] Zaccolo, M., De Giorgi, F., Cho, C.Y., Feng, L., Knapp, T.,
Negulescu, P.A., Taylor, S.S., Tsien, R.Y. and Pozzan, T. (2000)
A genetically encoded, ﬂuorescent indicator for cyclic AMP in
living cells. Nat. Cell Biol. 2, 25–29.
[29] Anand, G.S., Hughes, C.A., Jones, J.M., Taylor, S.S. and
Komives, E.A. (2002) Amide H/2H exchange reveals communi-
cation between the cAMP and catalytic subunit-binding sites in
the R (I)alpha subunit of protein kinase A. J. Mol. Biol. 323, 377–
386.
[30] Zawadzki, K.M. and Taylor, S.S. (2004) cAMP-dependent
protein kinase regulatory subunit type IIbeta: active site muta-
tions deﬁne an isoform-speciﬁc network for allosteric signaling by
cAMP. J. Biol. Chem. 279, 7029–7036.
[31] Zawadzki, K.M., Hamuro, Y., Kim, J.S., Garrod, S., Stranz,
D.D., Taylor, S.S. and Woods Jr., V.L. (2003) Dissecting
interdomain communication within cAPK regulatory subunit
type IIbeta using enhanced amide hydrogen/deuterium exchange
mass spectrometry (DXMS). Protein Sci. 12, 1980–1990.
[32] Zawadzki, K.M., Pan, C.P., Barkley, M.D., Johnson, D. and
Taylor, S.S. (2003) Endogenous tryptophan residues of cAPK
regulatory subunit type IIbeta reveal local variations in environ-
ments and dynamics. Proteins 51, 552–561.
[33] Sali, A. and Blundell, T.L. (1993) Comparative protein modelling
by satisfaction of spatial restraints. J. Mol. Biol. 234, 779–815.
[34] Sali, A. (1995) Modeling mutations and homologous proteins.
Curr. Opin. Biotechnol. 6, 437–451.
[35] Lindhal, E., Hess, B. and van der Spoel, D. (2001) Gromacs 3.0: A
package for molecular simulations and trajectory analysis. J. Mol.
Mod. 7, 306–317.
[36] Darden, T.A. and York, D. (1993) Particle mesh Ewald: an
N log(N) method for Ewald sums in large systems. J. Chem. Phys.
98, 10089–10094.
[37] Hess, B., Bekker, H., Berendsen, H. and Fraaije, J. (1997) LINCS:
a linear constraint solver for molecular simulations. J. Comp.
Chem. 18, 1463–1472.
[38] Nose, S. (1984) A molecular dynamics method for simulations in
the canonical ensamble. Mol. Phys. 52, 255–268.
[39] Hoover, W. (1984) Canonical dynamics: equilibrium phase-space
distributions. Phys. Rev. A 31, 1695–1697.
[40] Parrinello, M. and Rahman, A. (1981) Polymorphyc transitions in
single crystals: a new molecular dynamics approach. J. Appl.
Phys. 52, 7190–7192.
[41] Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K.M.,
Ferguson, D.M., Spellmayer, D.C., Fox, T., Caldwell, J.W. and
Kollman, P.A. (1995) A second generation force ﬁeld for the
simulation of proteins, nucleic acids and organic molecules. J.
Am. Chem. Soc. 117, 5179–5197.
[42] Jorgensen, W., Chandrasekhar, J., Madura, J. and Klein, M.
(1983) Comparison of simple potential functions for simulating
liquid water. J. Chem. Phys. 79, 926–935.[43] Punta, M., Cavalli, A., Torre, V. and Carloni, P. (2003)
Molecular modeling studies on CNG channel from bovine retinal
rod: a structural model of the cyclic nucleotide-binding domain.
Proteins 52, 332–338.
[44] Hirst, J.D. and Brooks III, C.L. (1994) Helicity, circular
dichroism and molecular dynamics of proteins. J. Mol. Biol.
243, 173–178.
[45] Connolly, M.L. (1983) Solvent-accessible surfaces of proteins and
nucleic acids. Science 221, 709–713.
[46] Ogreid, D. and Doskeland, S.O. (1981) The kinetics of the
interaction between cyclic AMP and the regulatory moiety of
protein kinase II. Evidence for interaction between the binding
sites for cyclic AMP. FEBS Lett. 129, 282–286.
[47] Wu, J., Jones, J.M., Nguyen-Huu, X., Ten Eyck, L.F. and Taylor,
S.S. (2004) Crystal structures of RIalpha subunit of cyclic
adenosine 5 0-monophosphate (cAMP)-dependent protein kinase
complexed with (Rp)-adenosine 3 0,50-cyclic monophosphothioate
and (Sp)-adenosine 30,50-cyclic monophosphothioate, the phos-
phothioate analogues of cAMP. Biochemistry 43, 6620–6629.
[48] Hamuro, Y., Zawadzki, K.M., Kim, J.S., Stranz, D.D., Taylor,
S.S. and Woods Jr., V.L. (2003) Dynamics of cAPK type IIbeta
activation revealed by enhanced amide H/2H exchange mass
spectrometry (DXMS). J. Mol. Biol. 327, 1065–1076.
[49] Canaves, J.M., Leon, D.A. and Taylor, S.S. (2000) Consequences
of cAMP-binding site mutations on the structural stability of the
type I regulatory subunit of cAMP-dependent protein kinase.
Biochemistry 39, 15022–15031.
[50] Nelson, N.C. and Taylor, S.S. (1983) Selective protection of
sulfhydryl groups in cAMP-dependent protein kinase II. J. Biol.
Chem. 258, 10981–10987.
[51] Herberg, F.W., Taylor, S.S. and Dostmann, W.R. (1996) Active
site mutations deﬁne the pathway for the cooperative activation of
cAMP-dependent protein kinase. Biochemistry 35, 2934–2942.
[52] Wainger, B.J., DeGennaro, M., Santoro, B., Siegelbaum, S.A.
and Tibbs, G.R. (2001) Molecular mechanism of cAMP modu-
lation of HCN pacemaker channels. Nature 411, 805–810.
[53] Schwede, F., Christensen, A., Liauw, S., Hippe, T., Kopperud, R.,
Jastorﬀ, B. and Doskeland, S.O. (2000) 8-Substituted cAMP
analogues reveal marked diﬀerences in adaptability, hydrogen
bonding and charge accommodation between homologous bind-
ing sites (AI/AII and BI/BII) in cAMP kinase I and II.
Biochemistry 39, 8803–8812.
[54] Heller, W.T., Vigil, D., Brown, S., Blumenthal, D.K., Taylor, S.S.
and Trewhella, J. (2004) C subunits binding to the protein kinase
A RI alpha dimer induce a large conformational change. J. Biol.
Chem. 279, 19084–19090.
[55] Zhao, J., Hoye, E., Boylan, S., Walsh, D.A. and Trewhella, J.
(1998) Quaternary structures of a catalytic subunit-regulatory
subunit dimeric complex and the holoenzyme of the cAMP-
dependent protein kinase by neutron contrast variation. J. Biol.
Chem. 273, 30448–30459.
[56] Kim, C., Xuong, N.H. and Taylor, S.S. (2005) Crystal structure of
a complex between the catalytic and regulatory (RIalpha)
subunits of PKA. Science 307, 690–696.
[57] Tung, C.S., Walsh, D.A. and Trewhella, J. (2002) A structural
model of the catalytic subunit-regulatory subunit dimeric complex
of the cAMP-dependent protein kinase. J. Biol. Chem. 277,
12423–12431.
